Sign in

CIK 0001661181

  • Accelerated filer

Organogenesis Holdings Inc.

Sign in to watch
Ticker
ORGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-575-0775
Business address
85 DAN ROAD, CANTON, MA, 02021
Former names
Avista Healthcare Public Acquisition Corp.
  1. 4 Open-market sale President and CEO sold 226,804 shares at an average $5.75 ($1,304,173)
  2. 4 Open-market sale President and CEO sold 197,336 shares at an average $5.68 ($1,120,557)
  3. 4 Open-market sale President and CEO sold 263,689 shares at an average $5.77 ($1,521,845)
  4. 4 Open-market buy 10% owner bought 10,000 shares at an average $6.03 ($60,298)
  5. 4 Open-market sale President and CEO sold 314,837 shares at an average $6.02 ($1,895,558)
  6. 4 Grant or award Director acquired 23,913 shares (grant or award)
  7. 4 Grant or award Director acquired 23,913 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Shares withheld for taxes Chief Commercial Officer gave up 1,977 shares (to pay taxes)
  11. 4 Shares withheld for taxes President and CEO gave up 9,789 shares (to pay taxes)
  12. 4 Shares withheld for taxes Vice President, Health Policy gave up 2,738 shares (to pay taxes)
  13. 4 Shares withheld for taxes VP and General Counsel gave up 2,984 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Operating Officer gave up 2,497 shares (to pay taxes)
  15. 4 Open-market sale Vice President, Health Policy sold 107,436 shares at an average $8.40 ($902,688)
  16. 4 Grant or award Director acquired 20,547 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Director acquired 20,547 shares (grant or award)
  19. 4 Grant or award Director acquired 20,547 shares (grant or award)
  20. 4 Grant or award Director acquired 20,547 shares (grant or award)

Page 8 of 17 · 321 filings